HRV Global Life Sciences marks history by exporting Indian-made Metformin to Argentina’s Mendoza. The initiative, backed by government partnerships and deregulation, introduces India’s virtual pharma model to Latin America’s public healthcare system, delivering affordability and cross-continental cooperation.
In a historic cross-continental healthcare shift, HRV’s Metformin shipment lands in Mendoza under $150K public health initiative, marking India’s growing role in global pharma.
In a defining moment for international pharmaceutical collaboration, HRV Global Life Sciences has achieved a landmark milestone by delivering the first-ever shipment of Indian-manufactured Metformin (1000mg) to Mendoza, Argentina. This milestone marks a new chapter in strengthening the health diplomacy between India and Argentina, offering affordable diabetes management solutions through Mendoza’s public health system.
This pioneering effort was made possible under the leadership of Alfredo Cornejo, Governor of Mendoza, and Dinesh Bhatia, Ambassador of India to Argentina. The initiative gained momentum following strategic deregulation led by President Javier Milei, Minister of Health Mario Lugones and Minister of Deregulation Federico Sturzenegger.
Backed by a $150,000 investment from the Mendoza provincial government, this procurement achieved an estimated 45–50% cost saving compared to conventional drug imports, emphasizing India’s increasing role in global pharmaceutical supply chains.
“This milestone delivery is not just about pharmaceutical logistics. It is about access, equity, and vision. We are proud to collaborate with Argentina to make quality medication affordable and widely accessible,” shared Hari Kiran Chereddi, Managing Director of HRV Global Life Sciences.
The consignment included USFDA-compliant Metformin manufactured through HRV’s Contract Development and Manufacturing Organization (CDMO) partner. This also serves as a successful validation of the company’s pioneering virtual pharma model – a first of its kind in India covering both Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs).
HRV Global Life Sciences, founded in 2015 and headquartered in Hyderabad, operates across USA, Switzerland, Dubai, Lithuania, and Turkey. It collaborates with over 55 Indian drug substance manufacturers and serves 100+ corporations across Europe, Latin America, and the Middle East.
This strategic collaboration not only highlights India’s leadership in cost-efficient, high-quality pharmaceuticals but also paves the way for future exports across Argentina’s other provinces and into additional therapeutic areas such as oncology and cardiology.
“Metformin is more than a medicine. It’s a lifeline for millions,” said Rodolfo Montero, Mendoza’s Minister of Health. “Our partnership with HRV Global Life Sciences proves that visionary policy combined with international cooperation can transform public healthcare.”
This initiative reflects a broader wave of global healthcare diplomacy where virtual pharmaceutical models from India are now reaching patients across continents, with sustainability and scalability at their core.
Published by Prittle Prattle News , featuring you virtuously. Editor: Smruti Bhalerao | Channel: @prittleprattlenews
At Prittle Prattle News, featuring you virtuously, we celebrate the commitment and innovation. Led by Editor-in-Chief Smruti Bhalerao, our platform is dedicated to sharing impactful stories that inspire change and create awareness. Follow us on LinkedIn, Instagram, and YouTube for more stories that matter.
